266 related articles for article (PubMed ID: 10094256)
1. Neurological complications of neurofibromatosis type 1 in adulthood.
Créange A; Zeller J; Rostaing-Rigattieri S; Brugières P; Degos JD; Revuz J; Wolkenstein P
Brain; 1999 Mar; 122 ( Pt 3)():473-81. PubMed ID: 10094256
[TBL] [Abstract][Full Text] [Related]
2. Neurological complications involving the central nervous system in neurofibromatosis type 1.
Hsieh HY; Wu T; Wang CJ; Chin SC; Chen YR
Acta Neurol Taiwan; 2007 Jun; 16(2):68-73. PubMed ID: 17685129
[TBL] [Abstract][Full Text] [Related]
3. Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas.
Byrne S; Connor S; Lascelles K; Siddiqui A; Hargrave D; Ferner RE
J Neurooncol; 2017 Jul; 133(3):609-614. PubMed ID: 28593402
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of (18)fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1.
Ferner RE; Lucas JD; O'Doherty MJ; Hughes RA; Smith MA; Cronin BF; Bingham J
J Neurol Neurosurg Psychiatry; 2000 Mar; 68(3):353-7. PubMed ID: 10675220
[TBL] [Abstract][Full Text] [Related]
5. Symptoms associated with malignancy of peripheral nerve sheath tumours: a retrospective study of 69 patients with neurofibromatosis 1.
Valeyrie-Allanore L; Ismaïli N; Bastuji-Garin S; Zeller J; Wechsler J; Revuz J; Wolkenstein P
Br J Dermatol; 2005 Jul; 153(1):79-82. PubMed ID: 16029330
[TBL] [Abstract][Full Text] [Related]
6. Neurofibromatosis 1-associated neuropathies: a reappraisal.
Drouet A; Wolkenstein P; Lefaucheur JP; Pinson S; Combemale P; Gherardi RK; Brugières P; Salama J; Ehre P; Decq P; Créange A
Brain; 2004 Sep; 127(Pt 9):1993-2009. PubMed ID: 15289270
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients.
Guillamo JS; Créange A; Kalifa C; Grill J; Rodriguez D; Doz F; Barbarot S; Zerah M; Sanson M; Bastuji-Garin S; Wolkenstein P;
Brain; 2003 Jan; 126(Pt 1):152-60. PubMed ID: 12477702
[TBL] [Abstract][Full Text] [Related]
8. A clinical study of type 1 neurofibromatosis in north west England.
McGaughran JM; Harris DI; Donnai D; Teare D; MacLeod R; Westerbeek R; Kingston H; Super M; Harris R; Evans DG
J Med Genet; 1999 Mar; 36(3):197-203. PubMed ID: 10204844
[TBL] [Abstract][Full Text] [Related]
9. Brain gliomas, hydrocephalus and idiopathic aqueduct stenosis in children with neurofibromatosis type 1.
Glombova M; Petrak B; Lisy J; Zamecnik J; Sumerauer D; Liby P
Brain Dev; 2019 Sep; 41(8):678-690. PubMed ID: 31000370
[TBL] [Abstract][Full Text] [Related]
10. Neurofibromatosis type 1 and the pediatric neurosurgeon: a 20-year institutional review.
Farmer JP; Khan S; Khan A; Ortenberg J; Freeman C; O'Gorman AM; Montes J
Pediatr Neurosurg; 2002 Sep; 37(3):122-36. PubMed ID: 12187057
[TBL] [Abstract][Full Text] [Related]
11. Association between benign and malignant peripheral nerve sheath tumors in NF1.
Tucker T; Wolkenstein P; Revuz J; Zeller J; Friedman JM
Neurology; 2005 Jul; 65(2):205-11. PubMed ID: 16043787
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor, basic fibroblast growth factor and epithelial growth factor receptor in peripheral nerve sheath tumors of neurofibromatosis type 1.
Friedrich RE; Beer C; Glatzel M; Hagel C
Anticancer Res; 2015 Jan; 35(1):137-44. PubMed ID: 25550544
[TBL] [Abstract][Full Text] [Related]
13. Neurofibromatosis type 1.
Anderson JL; Gutmann DH
Handb Clin Neurol; 2015; 132():75-86. PubMed ID: 26564071
[TBL] [Abstract][Full Text] [Related]
14. Neurosurgical implications of neurofibromatosis Type I in children.
Al-Otibi M; Rutka JT
Neurosurg Focus; 2006 Jan; 20(1):E2. PubMed ID: 16459992
[TBL] [Abstract][Full Text] [Related]
15. Neurofibromatosis type 1 (NF1): diagnosis and management.
Ferner RE; Gutmann DH
Handb Clin Neurol; 2013; 115():939-55. PubMed ID: 23931823
[TBL] [Abstract][Full Text] [Related]
16. Neurological outcomes and surgical complications in 221 spinal nerve sheath tumors.
Safaee MM; Lyon R; Barbaro NM; Chou D; Mummaneni PV; Weinstein PR; Chin CT; Tihan T; Ames CP
J Neurosurg Spine; 2017 Jan; 26(1):103-111. PubMed ID: 27472744
[TBL] [Abstract][Full Text] [Related]
17. Malignant peripheral nerve sheath tumours in neurofibromatosis type 1: MRI supports the diagnosis of malignant plexiform neurofibroma.
Mautner VF; Friedrich RE; von Deimling A; Hagel C; Korf B; Knöfel MT; Wenzel R; Fünsterer C
Neuroradiology; 2003 Sep; 45(9):618-25. PubMed ID: 12898075
[TBL] [Abstract][Full Text] [Related]
18. C2 neurofibromas in neurofibromatosis type 1: genetic and imaging characteristics.
Waqar M; Huson S; Evans DG; Ealing J; Karabatsou K; George KJ; Soh C
J Neurosurg Spine; 2018 Oct; 30(1):126-132. PubMed ID: 30485203
[TBL] [Abstract][Full Text] [Related]
19. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
Segal L; Darvish-Zargar M; Dilenge ME; Ortenberg J; Polomeno RC
J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859
[TBL] [Abstract][Full Text] [Related]
20. [Aqueductal stenosis in the neurofibromatosis type 1. Presentation of 19 infantile patients].
Pascual-Castroviejo I; Pascual-Pascual SI; Velázquez-Fragua R; Viaño J; Carceller-Benito F
Rev Neurol; 2007 Jul 1-15; 45(1):18-21. PubMed ID: 17620261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
